Croston GE - Search Results

1

Randomized, double-blind, phase 1a single-ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers.

Schmidt WK, Cortés-Puch I, McReynolds CB, Croston GE, Hwang SH, Yang J, Pedersen TL, Wagner KM, Pham TT, Hunt T, Hammock BD. Schmidt WK, et al. Among authors: croston ge. Clin Transl Sci. 2024 Sep;17(9):e70033. doi: 10.1111/cts.70033. Clin Transl Sci. 2024. PMID: 39300734 Free PMC article. Clinical Trial.

2

Quinagolide Treatment Reduces Invasive and Angiogenic Properties of Endometrial Mesenchymal Stromal Cells.

Iampietro C, Brossa A, Canosa S, Tritta S, Croston GE, Reinheimer TM, Bonelli F, Carosso AR, Gennarelli G, Cosma S, Benedetto C, Revelli A, Bussolati B. Iampietro C, et al. Among authors: croston ge. Int J Mol Sci. 2022 Feb 4;23(3):1775. doi: 10.3390/ijms23031775. Int J Mol Sci. 2022. PMID: 35163699 Free PMC article.

3

Protective Mechanism of the Selective Vasopressin V_1A Receptor Agonist Selepressin against Endothelial Barrier Dysfunction.

Barabutis N, Marinova M, Solopov P, Uddin MA, Croston GE, Reinheimer TM, Catravas JD. Barabutis N, et al. Among authors: croston ge. J Pharmacol Exp Ther. 2020 Nov;375(2):286-295. doi: 10.1124/jpet.120.000146. Epub 2020 Sep 17. J Pharmacol Exp Ther. 2020. PMID: 32943478

4

Comparative pharmacology of a new recombinant FSH expressed by a human cell line.

Koechling W, Plaksin D, Croston GE, Jeppesen JV, Macklon KT, Andersen CY. Koechling W, et al. Among authors: croston ge. Endocr Connect. 2017 Jul;6(5):297-305. doi: 10.1530/EC-17-0067. Epub 2017 Apr 27. Endocr Connect. 2017. PMID: 28450423 Free PMC article.

5

The utility of target-based discovery.

Croston GE. Croston GE. Expert Opin Drug Discov. 2017 May;12(5):427-429. doi: 10.1080/17460441.2017.1308351. Epub 2017 Mar 23. Expert Opin Drug Discov. 2017. PMID: 28306350 No abstract available.

6

Identification of novel subtype selective RAR agonists.

Piu F, Gauthier NK, Olsson R, Currier EA, Lund BW, Croston GE, Hacksell U, Brann MR. Piu F, et al. Among authors: croston ge. Biochem Pharmacol. 2005 Dec 19;71(1-2):156-62. doi: 10.1016/j.bcp.2005.10.025. Epub 2005 Nov 21. Biochem Pharmacol. 2005. PMID: 16303118

7

Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954).

Croston GE, Olsson R, Currier EA, Burstein ES, Weiner D, Nash N, Severance D, Allenmark SG, Thunberg L, Ma JN, Mohell N, O'Dowd B, Brann MR, Hacksell U. Croston GE, et al. J Med Chem. 2002 Nov 7;45(23):4950-3. doi: 10.1021/jm025551+. J Med Chem. 2002. PMID: 12408704

8

Functional cell-based uHTS in chemical genomic drug discovery.

Croston GE. Croston GE. Trends Biotechnol. 2002 Mar;20(3):110-5. doi: 10.1016/s0167-7799(02)01906-6. Trends Biotechnol. 2002. PMID: 11841862 Review.

9

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.

Weiner DM, Burstein ES, Nash N, Croston GE, Currier EA, Vanover KE, Harvey SC, Donohue E, Hansen HC, Andersson CM, Spalding TA, Gibson DF, Krebs-Thomson K, Powell SB, Geyer MA, Hacksell U, Brann MR. Weiner DM, et al. Among authors: croston ge. J Pharmacol Exp Ther. 2001 Oct;299(1):268-76. J Pharmacol Exp Ther. 2001. PMID: 11561089

10

A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.

Mukherjee R, Hoener PA, Jow L, Bilakovics J, Klausing K, Mais DE, Faulkner A, Croston GE, Paterniti JR Jr. Mukherjee R, et al. Among authors: croston ge. Mol Endocrinol. 2000 Sep;14(9):1425-33. doi: 10.1210/mend.14.9.0528. Mol Endocrinol. 2000. PMID: 10976920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters